Increased nitric oxide radicals in postmortem brain from patients with schizophrenia.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 15954198)

Published in Schizophr Bull on January 01, 2004

Authors

Jeffrey K Yao1, Sherry Leonard, Ravinder D Reddy

Author Affiliations

1: VA Pittsburgh Healthcare System (Bldg. #13), 7180 Highland Drive, Pittsburgh, PA 15206, USA. jkyao@pitt.edu

Articles citing this

Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron (2014) 1.77

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46

Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev (2010) 1.38

Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal (2011) 1.32

Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry (2013) 1.27

Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One (2010) 1.09

Oxidative stress and schizophrenia: recent breakthroughs from an old story. Curr Opin Psychiatry (2014) 1.03

Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull (2013) 0.98

Neurobiology of schizophrenia onset. Curr Top Behav Neurosci (2014) 0.96

Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci (2010) 0.93

Oxidative stress in schizophrenia: pathogenetic and therapeutic implications. Antioxid Redox Signal (2011) 0.89

High-resolution copy number variation analysis of schizophrenia in Japan. Mol Psychiatry (2016) 0.87

Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis. Front Cell Neurosci (2013) 0.86

Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study. J Zhejiang Univ Sci B (2006) 0.85

Impaired metabolic reactivity to oxidative stress in early psychosis patients. Schizophr Bull (2014) 0.85

Accelerated aging in schizophrenia patients: the potential role of oxidative stress. Aging Dis (2013) 0.81

Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder. Indian J Clin Biochem (2010) 0.81

Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition. BMC Psychiatry (2014) 0.81

Response of Mammalian Macrophages to Challenge with the Chlorovirus Acanthocystis turfacea Chlorella Virus 1. J Virol (2015) 0.80

DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond. Int J Mol Sci (2016) 0.79

Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls. Neuropsychopharmacology (2014) 0.76

Altered brain arginine metabolism in schizophrenia. Transl Psychiatry (2016) 0.75

Elevated plasma F2-isoprostane levels in schizophrenia. Schizophr Res (2016) 0.75

Serum trace element differences between Schizophrenia patients and controls in the Han Chinese population. Sci Rep (2015) 0.75

DNA Damage in Major Psychiatric Diseases. Neurotox Res (2016) 0.75

Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. Front Physiol (2015) 0.75

Articles by these authors

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry (2006) 2.63

Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93

Altered glutathione redox state in schizophrenia. Dis Markers (2006) 1.67

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biol Psychiatry (2010) 1.45

Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. Am J Psychiatry (2013) 1.34

Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr Res (2009) 1.32

The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep (2003) 1.26

Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet B Neuropsychiatr Genet (2003) 1.17

A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res (2009) 1.13

Maternal stress during pregnancy causes sex-specific alterations in offspring memory performance, social interactions, indices of anxiety, and body mass. Physiol Behav (2011) 1.09

Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One (2010) 1.09

Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry (2009) 1.06

The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function. Biochem Pharmacol (2011) 1.06

Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder. Schizophr Res (2009) 1.05

Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. J Mol Neurosci (2009) 1.03

Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am J Med Genet B Neuropsychiatr Genet (2007) 0.95

Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder. Prostaglandins Leukot Essent Fatty Acids (2010) 0.94

Regulation of a novel alphaN-catenin splice variant in schizophrenic smokers. Am J Med Genet B Neuropsychiatr Genet (2008) 0.94

Early biomarkers of psychosis. Dialogues Clin Neurosci (2005) 0.93

Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study. Mol Cell Endocrinol (2006) 0.93

Metabolic investigation in psychiatric disorders. Mol Neurobiol (2005) 0.90

Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids (2004) 0.90

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int J Neuropsychopharmacol (2011) 0.89

Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. Psychiatr Genet (2012) 0.89

Associations between purine metabolites and clinical symptoms in schizophrenia. PLoS One (2012) 0.89

Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers. J Neurosci (2007) 0.88

Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites. Biol Psychiatry (2002) 0.87

Admixture analysis of smooth pursuit eye movements in probands with schizophrenia and their relatives suggests gain and leading saccades are potential endophenotypes. Psychophysiology (2002) 0.86

Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis. Front Cell Neurosci (2013) 0.86

Strain dependent effects of prenatal stress on gene expression in the rat hippocampus. Physiol Behav (2011) 0.85

The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype. Physiol Behav (2010) 0.85

Input dysfunction, schizotypy, and genetic models of schizophrenia. Schizophr Res (2002) 0.85

Semantic memory in schizophrenia: association with cell membrane essential fatty acids. Schizophr Res (2008) 0.83

Membrane pathology in schizophrenia: implication for arachidonic acid signaling. ScientificWorldJournal (2002) 0.82

Fine-mapping reveals novel alternative splicing of the dopamine transporter. Am J Med Genet B Neuropsychiatr Genet (2010) 0.80

The effects of prenatal stress on alpha4 beta2 and alpha7 hippocampal nicotinic acetylcholine receptor levels in adult offspring. Dev Neurobiol (2013) 0.79

Are differential behavioral responses to smoking and smoking cessation in schizophrenia related to nicotinic receptor levels? Neuropsychopharmacology (2002) 0.78

Expression of immune genes on chromosome 6p21.3-22.1 in schizophrenia. Brain Behav Immun (2013) 0.78

Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7. J Mol Neurosci (2011) 0.78

Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α). J Biol Chem (2011) 0.78

Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Schizophr Res (2005) 0.77

A simplified method to quantify dysregulated tyrosine transport in schizophrenia. Schizophr Res (2013) 0.76

Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder. Mol Cytogenet (2012) 0.75